Thrilled to share that I've been appointed Chief of Hematology
@StanfordDeptMed
starting May 2024! Honored to take over this role from the phenomenal Dr. Bev Mitchell & to follow distinguished prior Chairs: Drs. Ravi Majeti
@majetiLab
, Linda Boxer, Larry Leung & Stan Schrier. /1
Thrilled to share our latest paper out now
@BloodJournal
: Whole-genome CRISPR screening identifies N-glycosylation as a genetic and therapeutic vulnerability in CALR-mutant MPNs
Our latest paper is out in First Ed
@BloodAdvances
!
Genomic Profiling of a Randomized Trial of Interferon-α versus Hydroxyurea in MPN Reveals Mutation-Specific Responses | Blood Advances | American Society of Hematology
Hello California! ☀️
Excited to start next week
@StanfordDeptMed
as Heme Chief
@StanfordMed
My lab is actively recruiting, pls DM me if interested in joining us to study
#MPN
in sunny California! ☀️😎
We studied newly diagnosed patients with ET and PV,
reconstructing the lineage history & differentiation trajectories of individual JAK2V617F HSC - here is our preprint will full details
#MPNsm
A highlight of my time
@BrighamHeme
has been scientific interactions with Dr. Peter van Galen
@vangalenlab
, one of the most generous, thoughtful & forwarding thinking scientists I know. Our labs have benefited so much from our joint lab meeting!
@BrighamResearch
@broadinstitute
9/10
#BestofCellStemCell
Sahand Hormoz & Co
@harvardmed
use single-cell transcriptomics and whole-genome sequencing of stem cells from individuals with MPN and found evidence that a oncogenic mutation can occur in a single HSC decades before diagnosis.
As incoming Heme Chief
@StanfordDeptMed
, a high priority is expanding the outstanding
@StanfordHeme
faculty! We're seeking a
#physicianscientist
in heme malignancies; candidates with experience in clinical trials and/or translational research with lab aspect encouraged to apply!
First in-person
@MullallyLab
retreat since 2019!
So great to come together in the beautiful
@Harvard
campus to brainstorm on science, learn more about each other's backgrounds & career goals & of course enjoy lunch together - fab day!
@BrighamHeme
@BrighamResearch
@harvardmed
As
#ASH2023
approaches, I wanted to share some
@ASH_hematology
abstracts from our MPN cohort
@DanaFarber
@BrighamHeme
now comprising approx 1300 patients on whom we have comprehensive molecular genetic profiling, clinical data, labs and pathology. Three abstracts to follow
#MPNsm
Since I'm attending
#ASH21
virtually this year & normally meet postdoc candidates in-person at the meeting, please email me if you're interested in joining
@MullallyLab
- we are recruiting!
#MPNsm
Our review "Biology & therapeutic targeting of molecular mechanisms in MPN" is out
@BloodJournal
, big thanks to my co-authors
@joanhowMD
& Dr. Jacqueline Garcia - hope all in MPN community find this useful, comments welcome!
@BrighamHeme
@DanaFarber
#mpnsm
New Short Article online now CellStemCell: Reconstructing the Lineage Histories and Differentiation Trajectories of Individual Cancer Cells in Myeloproliferative Neoplasms
Congress|
#ASH21
| Anna Marneth
@harvardmed
, describes data on a whole-genome CRISPR screen that identified N-glycosylation as an essential pathway for mutant CALR-driven oncogenesis; highlighting it as a potential novel therapeutic target for patients with CALR-mutant MPN.
#MPNsm
Congrats to Kate, Julie & everyone in
@JulieLosman
Lab, as well as collaborators, on this interesting study identifying KDM5 as a 2-HG target in IDH-mutant cancers - have seen this story develop in our shared lab meeting
@DanaFarber
- beautiful work, great to see it out
@CD_AACR
!
Now online in
@CD_AACR
: (R)-2-hydroxyglutarate Inhibits KDM5 Histone Lysine Demethylases to Drive Transformation in IDH-mutant Cancers - by Kathryn Gunn,
@JulieLosman
, and colleagues
@DanaFarber
Fresh faces & exciting developments in Hematology's Spring Newsletter! Meet
@StanfordHeme
's new Division Chief Ann Mullally (
@MullallyLab
) & learn about the latest faculty awards & clinical trials:
Congrats to Dr.
@jonas_jutzi
, postdoc
@MullallyLab
on leading this study entitled, "CALR-mutated cells are vulnerable to combined inhibition of the proteasome and the endoplasmic reticulum stress response" now published in
@LeukemiaJnl
! Read paper here:
Thank you to Dr. Ann Mullally (
@MullallyLab
) for the fascinating talk on P53 in MPN. Dr. Mullally’s lab has worked to establish an incredible collection of P53 mutant MPN pt samples, using them to show P53 multi-hit mutations are associated with reduced survival.
#ESHMPN2024
Over 500 attendees
@EHA_Hematology
Mol Heme Workshop this morn' for a really fantastic & inspiring session! So thankful to all the presenters, to
@EHA_Hematology
staff, to my fab co-chairs Dr. Kim De Keersmaecker,
@MilsomMick
& especially to Dr. Thomas Mercher for leading us all!
#ASH22
|
@AnnaMarneth
@harvardmed
gives a talk on how SRSF2mut lowers JAK2 erythrocytosis in mice and is linked with lower Hb in pts with chronic JAK2mut
#MPN
. She highlights that the data may help identify novel therapeutic targets to reduce anaemia
#MPNsm
#medicalcongress
Congrats
@RossLevineLab
& colleagues on this great paper on CXCL8/CXCR2 in myelofibrosis:
@StevenLane_QIMR
, could it be that you're invoking Dylan in the
@BloodJournal
commentary?
Shelter from the cytokine storm in myelofibrosis
Wonderful profile of former
@MullallyLab
postdoctoral fellow, Dr. Shannon Elf, now blazing her own trail
@UChicago
! Congrats to Shannon on
@LLSResearch
CDP Achievement Award. So proud of Shannon’s accomplishments & honored to be in the esteemed group of her mentors.
: CDP Achievement Award winner Shannon Elf is featured in our latest Spotlight! Having started her career dissecting mutant CALR in MPNs
@BrighamWomens
, Dr. Elf now leads a
@UCCancerCenter
lab
@UChicago
identifying other pathways critical for
#MPN
and
#AML
.
Backstage, Green Room,
#ASH18
Plenary Session, just a few minutes before “curtain”. Everyone acting composed... but trembling hands and rapid JVP waves speak of the fact that I am not the only one w/ sinus tach! Hanging out with Dr Ann Mullally
@BrighamWomens
in queue for makeup
Review from Dr. Jonas Jutzi (
@MullallyLab
) and I out now!
#MPNsm
Remodeling the Bone Marrow Microenvironment – A Proposal for Targeting Pro-inflammatory Contributors in MPN
Very excited to chair a session in fantastic EHA Molecular Hematopoiesis Workshop, which takes place TOMORROW, June 9, from 9:00 to 12:00 CEST!
(i.e. 3:00 to 6:00 EDT, ready for an early start!)
2 days left till🚀
#EHA2021
Virtual! Stay tuned for 9 exciting Congress days offering you the latest news and developments in
#hematology
and its sub specialties. (All sessions will be available on-demand on the Congress platform until August 15!) Register:
Great to re-connect with the amazing
@rschneiderlab
, Scientific Committee Member for the Annual
@oncodeinstitute
Meeting, congrats to Rebekka & everyone involved this wonderful meeting!
Tonight at
#ASH2019
, I will be discussing JAK-STAT signaling, ruxolitinib, fedratinib & an interesting case of PV from my clinic! Should be a great session on PV & MF!
#mpnsm
My Friday night plans at
#ASH2019
!
MPN Tumor Board: Application of Novel Agents for the Treatment of PV & MF. Fri. Dec 06, 6pm - 10pm
Hyatt Regency Orlando, Plaza International I-K
Chair: Ronald Hoffman, MD
Speakers: Rami S. Komrokji, MD
Ann Mullally, MD
Abdulraheem Yacoub, MD
#ASH22
great sessions today! I am looking fwd to more tomorrow, excited to co-chair (with
@FD_Camargo
) the scientific session on Cell Competition & Clonal Hematopoiesis! Speakers Dr Laura Johnston,
@AlejoFraticelli
@MullallyLab
& Dominique Bonnet. New Orleans Theater AB 9.30am.
As physician-scientists we are an endangered species! Many potential reasons for this but early career funding specifically for this group is key I think. Grateful to
@DamonRunyon
and
@LLSResearch
for recognizing this & supporting us!
Committed to investing in research that could lead to a better understanding & prevention of progression from PV/ET to MF,
#MPNRF
has made its first strategic investment in this area with a 1yr grant to Dr. Ann Mullally (
@MullallyLab
) at
@DanaFarber
#MPNSM
Congress|
#EHA2022
Jonas Jutzi,
@BrighamHeme
discusses the mechanisms by which CALR mut cells alleviate ER stress and how to exploit this. He highlights that disrupted proteasis results in dependency on the IRE1-XPB1 axis of the UPR and proteasome activity
#MPN
#medicalcongress
Just wanted to introduce Dr. Joan How to
@ESHaematology
community. Joan is finishing heme/onc fellowship
@df_hcc
and will start as faculty
@BrighamHeme
this summer. She has a long track record of
#mpn
research with
@mpndoc
,
@GabyHobbs
& I. Please welcome Joan to our MPN group!
Congrats to all the recipients of
@ASH_hematology
2024 Honorific Awards! A big
@StanfordHeme
shout out to Dr. Ami Bhatt, recipient of the Dameshek Award. Our Division is so proud of Ami on this well deserved award & the honor it brings to her, to all of us & to
@StanfordDeptMed
!
A huge
#ASHKudos
to the 2024 ASH Honorific Award recipients! This year’s recipients are a group of pioneering scientists, innovative clinicians, and selfless mentors who have advanced hematology through vital contributions!
#ASHAwards
#ASH24
#hematology
I am chairing part three of EHA Mol Heme Workshop on transcriptional & epigenetic regulation starting at 11am CEST tomorrow June 9 - speakers are Daniel Coleman,
@JulesMeijerink
, Cryril Broccardo, Marlies Rossmann &
@lindemilesphd
- promises to be a great session!
2 days left till🚀
#EHA2021
Virtual! Stay tuned for 9 exciting Congress days offering you the latest news and developments in
#hematology
and its sub specialties. (All sessions will be available on-demand on the Congress platform until August 15!) Register:
#ASH20
#LBA1
. Superb presentation and
#ASHKudos
to Dr .
@jyoti_nangalia
& team !!! Congratulations on the is amazing ground-breaking work in our
#MPNSM
field !! Driver mutation Acquisition in utero & childhood followed by lifelong Clonal evolution underlie MPNs
@ASH_hematology
Proud to contribute a recorded lecture on MPN for this Hematology Review Series organized by
@ASH_hematology
for fellows & trainees!
#mpnsm
Hematology Review Series -
Fascinating biology also relevant to MPN where germline variants in TERT are associated with MPN risk, as reported by
@bloodgenes
& others and patients with MPN have shorter telomeres. Great Tweetorial
@pnatarajanmd
!
#MPNsm
Super cool observation that a monogenic mechanism of longer telomeres yields familial clonal hematopoiesis of indeterminate potential.
@NEJM
This is super cool bc it's not the expectation as
@ginakolata
@nytimes
explains ()
🧵👇
As
#ASH2023
approaches, I wanted to share some
@ASH_hematology
abstracts from our MPN cohort
@DanaFarber
@BrighamHeme
now comprising approx 1300 patients on whom we have comprehensive molecular genetic profiling, clinical data, labs and pathology. Three abstracts to follow
#MPNsm
My Friday night plans at
#ASH2019
!
MPN Tumor Board: Application of Novel Agents for the Treatment of PV & MF. Fri. Dec 06, 6pm - 10pm
Hyatt Regency Orlando, Plaza International I-K
Chair: Ronald Hoffman, MD
Speakers: Rami S. Komrokji, MD
Ann Mullally, MD
Abdulraheem Yacoub, MD
Highly recommend this Tweetorial and preprint dissecting the biology of blast phase MPN.
@CKBrierley
gave an outstanding presentation of this elegant and important work at
#ASH23
, definitely one of my highlights of the meeting! Congrats to all involved!
@ASH_hematology
#MPNsm
Heading home from
#ASH23
? 👩💼🌞🌮Stuck in a line at security or facing a long layover? ✈️In withdrawal from all the amazing science? 🧪🧬 Read our preprint from my PhD work
@UniofOxford
@MRC_WIMM
presented in the MPN session yesterday! 1/n
MPN meets Montaigne! Nice commentary from Drs. Norfo & Mead - with new MPN insights come more questions!
@AdamMead_Oxford
@ASH_hematology
#MPNsm
Clonal Selection of Mutant HSC in MPN: “What Do I Know?” | The Hematologist | American Society of Hematology
Bywater & Lane
@QIMRBerghofer
provide insights into work by
Dagher et al () who combine arsenic & interferon α to deliver a knockout punch to myeloproliferative neoplasm (MPN) stem cells & provide new hope to cure patients with MPNs
Congrats to
@HmzaCelik
@challenlab
@mpndoc
& all authors of this detailed study
@CD_AACR
showing that MPN PDX models are feasible. Interesting that sub-clinical "aggressive" sub-clones were positively selected for in vivo. CD34+ cells injected via intra-tibial injection!
#MPNsm
The
@HmzaCelik
legacy paper. We hope all MPN researchers can adopt this model to study primary patient cells in vivo. Let us know if we can help. Big thanks to
@CD_AACR
, collaborators like
@mpndoc
, funding bodies
@LLSusa
@nih_nhlbi
and of course our patients!
Check out our poster at
#ASH19
on genomics & interferon in MPN. Mon 6-8pm. Interesting findings on CALR & DNMT3A mutations. Great collaboration with Danish MPN investigators &
@ColemanLindsley
, funded by
@MPN_RF
@LLSResearch
#MPNSm
@KharasLab
describes innovative ways to study RNA binding proteins in HSC, kicking off a fantastic molecular hematopoiesis workshop this morning
@EHA_Hematology
in the wonderful city of Amsterdam! 🚲🇳🇱
#EHA24
Happy
#InternationalWomensDay
to all of our
#shematologists
who work with us! 🎉 Today we give a special thanks to our Women In Hematology Working Group who are dedicated to supporting the careers of women hematologists.
Check out this review, co-authored with Dr. Frederike Kramer
@MullallyLab
@BrighamHeme
@BrighamResearch
#MPNsm
Antibody targeting of mutant calreticulin in myeloproliferative neoplasms - Journal of Cellular and Molecular Medicine - Wiley Online Library
Come join us
@BrighamHeme
@BrighamResearch
Great environment, phenomenal colleagues, exceptional trainees and Boston winters really aren't that bad, haha!
The Hematology Division
@BrighamWomens
@harvardmed
is recruiting for clinical faculty as well as basic/translational science faculty positions. See attached description for details.
❓ Did you know that epigenetic therapies can potentially change the path of a patient’s journey with myelofibrosis? Join experts
@MullallyLab
, John Mascarenhas, MD, MS, Claire N. Harrison, DM, FRCP, FRCPath & Ronald Hoffman, MD December 8 at
#ASH2023
👉